natalizumab

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago